GNVs addition significantly reduced NLRP3 and IL-1β gene expression in HC monocytes (NLRP3: p = 0.02; IL-1β: p = 0.05 vs. LPS + nigericin-stimulated cells) but it did not have an effect in AD cells. The gene discussed is NLRP3; the disease is Alzheimer disease.